These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 2875821

  • 1. Pharmacokinetics and effects of intravenous infusion of somatostatin in normal subjects--a two-compartment open model.
    Ho LT, Chen RL, Chou TY, Fong JC, Wang PS, Chou CK.
    Clin Physiol Biochem; 1986; 4(4):257-67. PubMed ID: 2875821
    [Abstract] [Full Text] [Related]

  • 2. A-Cell and gut glucagon in normal and depancreatized dogs. Inhibition by somatostatin and insulin.
    Matsuyama T, Wider MD, Tanaka R, Shima K, Tarui S, Nishikawa M, Foà PP.
    Diabete Metab; 1979 Jun; 5(2):141-7. PubMed ID: 478084
    [Abstract] [Full Text] [Related]

  • 3. Possible mechanisms and significance of the neonatal surge in glucagon secretion: studies in newborn lambs.
    Grajwer LA, Sperling MA, Sack J, Fisher DA.
    Pediatr Res; 1977 Jul; 11(7):833-6. PubMed ID: 876705
    [Abstract] [Full Text] [Related]

  • 4. Metabolic effects of graded glucagon infusions in man: inhibition of glucagon, insulin, and somatostatin response to arginine.
    Pontiroli AE, Perfetti MG, Andreotti AC, Fattor B, Monti LD, Pozza G.
    Metabolism; 1993 Oct; 42(10):1242-8. PubMed ID: 8105365
    [Abstract] [Full Text] [Related]

  • 5. Response of plasma somatostatin-like immunoreactivity to the administration of alloxan in dogs.
    Schusdziarra V, Harris V, Unger R.
    Horm Metab Res; 1979 Aug; 11(8):457-9. PubMed ID: 499995
    [Abstract] [Full Text] [Related]

  • 6. Low-dose infusion of somatostatin in man--no effect upon intestinal calcium absorption but a fall in blood insulin.
    Rümenapf G, Hanisch E, Schwille PO.
    Exp Clin Endocrinol; 1986 Aug; 87(3):306-12. PubMed ID: 2877894
    [Abstract] [Full Text] [Related]

  • 7. Effects of cyclic somatostatin on insulin, C-peptide and immunoreactive glucagon response to oral glucose loading in obese patients.
    Papalia D, Trovato G, Maugeri D, Tribulato A, Lunetta M.
    Int J Obes; 1982 Aug; 6(1):113-20. PubMed ID: 6121763
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of somatostatin in regulating pancreatic splenic lobe hormone secretion following 99% pancreatectomy in adult chickens.
    Cieslak SR, Hazelwood RL.
    Gen Comp Endocrinol; 1986 Aug; 63(2):284-94. PubMed ID: 2877920
    [Abstract] [Full Text] [Related]

  • 9. Effect of somatostatin in the Syrian hamster bearing a transplantable islet-cell tumor.
    Luyckx AS, Lefebvre PJ.
    Horm Metab Res; 1978 Mar; 10(2):105-10. PubMed ID: 206496
    [Abstract] [Full Text] [Related]

  • 10. Plasma somatostatin in normal subjects and in various diseases: increased levels in somatostatin-producing tumors.
    Saito H, Saito S.
    Horm Metab Res; 1982 Feb; 14(2):71-6. PubMed ID: 6121747
    [Abstract] [Full Text] [Related]

  • 11. Establishment of a radioimmunoassay of somatostatin in human plasma and in rat hypothalamus.
    Ho LT, Lam HC, Wang JT, Tang KT, Perng JC, Liu YF, Chen RL.
    Chin J Physiol; 1986 Feb; 29(2):91-103. PubMed ID: 2884084
    [Abstract] [Full Text] [Related]

  • 12. Effect of a 12-hour subcutaneous infusion of somatostatin-14 on blood glucose, insulin and glucagon levels in healthy subjects and insulin dependent diabetics.
    Villaume C, Beck B, Kolopp M, Toussain P, Debry G.
    Biomed Pharmacother; 1986 Feb; 40(2):61-4. PubMed ID: 2875745
    [Abstract] [Full Text] [Related]

  • 13. Somatostatin infusion inhibits glucose production in burn patients.
    Wolfe RR, Burke JF.
    Circ Shock; 1982 Feb; 9(5):521-7. PubMed ID: 6129073
    [Abstract] [Full Text] [Related]

  • 14. Reversal of somatostatin inhibition of insulin and glucagon secretion.
    Bhathena SJ, Perrino PV, Voyles NR, Smith SS, Wilkins SD, Coy DH, Schally AV, Recant L.
    Diabetes; 1976 Nov; 25(11):1031-40. PubMed ID: 992224
    [Abstract] [Full Text] [Related]

  • 15. Physiologic modeling of the intravenous glucose tolerance test in type 2 diabetes: a new approach to the insulin compartment.
    Ward GM, Walters JM, Barton J, Alford FP, Boston RC.
    Metabolism; 2001 May; 50(5):512-9. PubMed ID: 11319711
    [Abstract] [Full Text] [Related]

  • 16. Effects of glucocorticoids on hepatic sensitivity to insulin and glucagon in man.
    Dirlewanger M, Schneiter PH, Paquot N, Jequier E, Rey V, Tappy L.
    Clin Nutr; 2000 Feb; 19(1):29-34. PubMed ID: 10700531
    [Abstract] [Full Text] [Related]

  • 17. Hormonal and metabolic effects of near physiological increase of plasma immunoreactive somatostatin 14.
    Souquet JC, Rambliere R, Riou JP, Beylot M, Cohen R, Mornex R, Chayvialle JA.
    J Clin Endocrinol Metab; 1983 May; 56(5):1076-9. PubMed ID: 6131904
    [Abstract] [Full Text] [Related]

  • 18. Effect of guar intake on plasma somatostatin-like immunoreactivity in diabetic patients.
    Shimoyama R, Uehara S, Itagaki Y, Izumiyama S, Hirayama A.
    Hokkaido Igaku Zasshi; 1982 Nov; 57(6):727-33. PubMed ID: 6134660
    [Abstract] [Full Text] [Related]

  • 19. Half-life of somatostatin-like immunoreactivity in canine plasma.
    Schusdziarra V, Harris V, Unger RH.
    Endocrinology; 1979 Jan; 104(1):109-10. PubMed ID: 446338
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of motilin in man.
    Mitznegg P, Bloom SR, Domschke W, Domschke S, Wuensch E, Demling L.
    Gastroenterology; 1977 Mar; 72(3):413-6. PubMed ID: 832789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.